IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate

Simply Wall St.05-20

IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows veterinarians in the US and Canada to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2636971318?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/29729-main-header/1756252961457","is_english":true,"pubTime":"2026-05-20 11:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2636971318","market":"sg","top_or_hot":-1,"title":"IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate","media":"Simply Wall St.","content":"<div>\n<p>IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows veterinarians in the US and Canada to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-sdma-rollout-ties-earlier-kidney-detection-to-valuatio\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-20 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-sdma-rollout-ties-earlier-kidney-detection-to-valuatio><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows veterinarians in the US and Canada to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-sdma-rollout-ties-earlier-kidney-detection-to-valuatio\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2404859741.USD","symbol_name":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-sdma-rollout-ties-earlier-kidney-detection-to-valuatio","article_id":"2636971318","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/29729-main-header/1756252961457"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-sdma-rollout-ties-earlier-kidney-detection-to-valuatio","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2636971318","pubTimestamp":1779247648,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles.\nThe update allows veterinarians in the US and Canada to detect kidney disease in pets earlier through routine bloodwork.\nClinics can access SDMA testing without changing existing workflows or investing in separate assays.\nThe move aligns the Catalyst platform with international veterinary kidney disease guidelines.\n\n\nIDEXX Laboratories focuses on...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","BK4082":"医疗保健设备","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","BK4504":"桥水持仓","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC","BK4588":"碎股","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IDXX":"爱德士实验室","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC"},"translate_title":"IDEXX SDMA的推出将早期肾脏检测与估值争论联系起来","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDXX":0.9},"content_text":"IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows veterinarians in the US and Canada to detect kidney disease in pets earlier through routine bloodwork. Clinics can access SDMA testing without changing existing workflows or investing in separate assays. The move aligns the Catalyst platform with international veterinary kidney disease guidelines.   IDEXX Laboratories focuses on veterinary diagnostics and software tools used in everyday clinical practice. By adding SDMA into existing Catalyst chemistry profiles, the company is using its installed base to expand access to kidney monitoring that fits into current testing habits.\n  For investors looking at NasdaqGS:IDXX, this product update highlights how new biomarkers can be layered onto existing analyzers rather than requiring fresh hardware rollouts. It also provides a development to follow as clinics incorporate guideline-based kidney screening into standard in-clinic panels over time.\n Stay updated on the most important news stories for IDEXX Laboratories by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on IDEXX Laboratories. NasdaqGS:IDXX Earnings & Revenue Growth as at May 2026 4 things going right for IDEXX Laboratories that this headline doesn't cover. AdvertisementQuick Assessment  ✅ Price vs Analyst Target: At US$546.49, the stock trades about 23% below the US$709.14 analyst price target. ⚖️ Simply Wall St Valuation: Simply Wall St views the shares as trading close to estimated fair value. ❌ Recent Momentum: The stock is down 7.3% over the past 30 days.  There is only one way to know the right time to buy, sell or hold IDEXX Laboratories. Head to Simply Wall St's\ncompany report for the latest analysis of IDEXX Laboratories's Fair Value. Key Considerations  📊 SDMA integration into Catalyst profiles reinforces in-clinic testing as a core part of the business and may deepen ties with veterinarians. 📊 Watch how quickly SDMA adoption grows in routine panels, and track any commentary on test volumes and recurring diagnostics revenue. ⚠️ With a P/E of about 39x against a medical equipment industry average near 25x, sentiment may be sensitive to any slowdown in utilization or new product uptake.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete IDEXX Laboratories analysis. Alternatively, you can check out the\ncommunity page for IDEXX Laboratories to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2636971318","isCrawlerRequest":true}